RecruitingPhase 2NCT06226883A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseSponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)Fayetteville, NC · High Point, NC · Raleigh, NC · +22 more sites
RecruitingPhase 3NCT06937099Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightSponsor: Eli Lilly and CompanyFayetteville, NC · +34 more sites
RecruitingPhase 3NCT07184931An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseSponsor: SanofiChapel Hill, NC · Charlotte, NC · Durham, NC · +122 more sites
RecruitingPhase 3NCT07184944A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseSponsor: SanofiChapel Hill, NC · Fayetteville, NC · +32 more sites